Entering text into the input field will update the search result below

iBio shares surge after resolving Fraunhofer USA lawsuit

  • iBio (NYSE:IBIO) shares climb nearly 20% during after-market trading on resolving its lawsuit with Fraunhofer USA.
  • The settlement confirms iBio’s ownership of certain intellectual property related to plant-based biopharmaceutical production.
  • As part of the settlement, iBio granted Fraunhofer a fully paid-up license to use

Recommended For You

About IBIO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
IBIO--
iBio, Inc.